Using scRNAseq data, we further explored the expressional status of these 34 genes in breast cancer BoM samples from a TME perspective, identified a BoM-related component, and further verified the existence of this component in BoM samples of two other cancers (prostate cancer and renal cancer). Here, GRHL2 is linked to cancer.